- Home
- ELVN vs FWRG Comparison
ELVN vs FWRG Comparison
Compare ELVN & FWRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- FWRG
- Stock Information
- Founded
- ELVN 2016
- FWRG 1983
- Country
- ELVN United States
- FWRG United States
- Employees
- ELVN N/A
- FWRG N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- FWRG Restaurants
- Sector
- ELVN Health Care
- FWRG Consumer Discretionary
- Exchange
- ELVN Nasdaq
- FWRG Nasdaq
- Market Cap
- ELVN 1.1B
- FWRG 1.1B
- IPO Year
- ELVN 2020
- FWRG 2021
- Fundamental
- Price
- ELVN $21.99
- FWRG $18.34
- Analyst Decision
- ELVN Strong Buy
- FWRG Strong Buy
- Analyst Count
- ELVN 5
- FWRG 10
- Target Price
- ELVN $37.80
- FWRG $23.50
- AVG Volume (30 Days)
- ELVN 242.0K
- FWRG 459.5K
- Earning Date
- ELVN 03-13-2025
- FWRG 03-04-2025
- Dividend Yield
- ELVN N/A
- FWRG N/A
- EPS Growth
- ELVN N/A
- FWRG N/A
- EPS
- ELVN N/A
- FWRG 0.33
- Revenue
- ELVN N/A
- FWRG $997,252,000.00
- Revenue This Year
- ELVN N/A
- FWRG $16.31
- Revenue Next Year
- ELVN N/A
- FWRG $15.33
- P/E Ratio
- ELVN N/A
- FWRG $55.39
- Revenue Growth
- ELVN N/A
- FWRG 19.77
- 52 Week Low
- ELVN $10.90
- FWRG $12.90
- 52 Week High
- ELVN $30.03
- FWRG $25.98
- Technical
- Relative Strength Index (RSI)
- ELVN 44.20
- FWRG 44.20
- Support Level
- ELVN $20.16
- FWRG $18.26
- Resistance Level
- ELVN $23.08
- FWRG $20.06
- Average True Range (ATR)
- ELVN 1.66
- FWRG 0.73
- MACD
- ELVN -0.06
- FWRG -0.10
- Stochastic Oscillator
- ELVN 35.12
- FWRG 18.66
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.